Legend Biotech Net Worth
Legend Biotech Net Worth Breakdown | LEGN |
Legend Biotech Net Worth Analysis
Legend Biotech's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Legend Biotech's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Legend Biotech's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Legend Biotech's net worth analysis. One common approach is to calculate Legend Biotech's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Legend Biotech's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Legend Biotech's net worth. This approach calculates the present value of Legend Biotech's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Legend Biotech's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Legend Biotech's net worth. This involves comparing Legend Biotech's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Legend Biotech's net worth relative to its peers.
Enterprise Value |
|
To determine if Legend Biotech is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Legend Biotech's net worth research are outlined below:
| Legend Biotech Corp generated a negative expected return over the last 90 days | |
| Legend Biotech Corp has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 285.14 M. Net Loss for the year was (518.25 M) with loss before overhead, payroll, taxes, and interest of (284.01 M). | |
| Legend Biotech Corp currently holds about 791.26 M in cash with (393.28 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.11. | |
| Latest headline from insidermonkey.com: Why Is Legend Biotech Corporation Among the Worst Performing Biotech Stocks in 2024 |
Legend Biotech uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Legend Biotech Corp. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Legend Biotech's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 4th of April 2024 Upcoming Quarterly Report | View | |
| 16th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 4th of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Legend Biotech's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Legend Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Legend Biotech Corp backward and forwards among themselves. Legend Biotech's institutional investor refers to the entity that pools money to purchase Legend Biotech's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Braidwell Lp | 2024-09-30 | 1.5 M | Federated Hermes Inc | 2024-09-30 | 1.5 M | Citadel Advisors Llc | 2024-06-30 | 1.4 M | Timessquare Capital Management, Llc | 2024-09-30 | 1.2 M | State Street Corp | 2024-06-30 | 1.1 M | Alliancebernstein L.p. | 2024-06-30 | 1.1 M | Arrowmark Colorado Holdings, Llc (arrowmark Partners) | 2024-06-30 | 1.1 M | Matthews International Cap Mgmt Llc | 2024-09-30 | 1 M | Johnson & Johnson | 2024-06-30 | 814.6 K | Fmr Inc | 2024-09-30 | 18.3 M | T. Rowe Price Associates, Inc. | 2024-06-30 | 11.5 M |
Follow Legend Biotech's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 7.29 B.Market Cap |
|
Project Legend Biotech's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.28) | (0.30) | |
| Return On Capital Employed | (0.27) | (0.28) | |
| Return On Assets | (0.28) | (0.29) | |
| Return On Equity | (0.41) | (0.43) |
When accessing Legend Biotech's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Legend Biotech's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Legend Biotech's profitability and make more informed investment decisions.
Evaluate Legend Biotech's management efficiency
Legend Biotech Corp has return on total asset (ROA) of (0.1228) % which means that it has lost $0.1228 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2835) %, meaning that it created substantial loss on money invested by shareholders. Legend Biotech's management efficiency ratios could be used to measure how well Legend Biotech manages its routine affairs as well as how well it operates its assets and liabilities. As of the 22nd of November 2024, Return On Tangible Assets is likely to drop to -0.3. In addition to that, Return On Capital Employed is likely to drop to -0.28. At this time, Legend Biotech's Net Tangible Assets are very stable compared to the past year. As of the 22nd of November 2024, Non Current Assets Total is likely to grow to about 368.4 M, while Total Assets are likely to drop about 938.8 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 7.11 | 7.46 | |
| Tangible Book Value Per Share | 7.08 | 7.44 | |
| Enterprise Value Over EBITDA | (20.18) | (19.18) | |
| Price Book Value Ratio | 8.47 | 8.04 | |
| Enterprise Value Multiple | (20.18) | (19.18) | |
| Price Fair Value | 8.47 | 8.04 | |
| Enterprise Value | 9.6 B | 5.2 B |
At Legend Biotech Corp, effective management practices are pivotal to sustaining long-term profitability. We delve into financial metrics and market conditions to provide a comprehensive analysis of the stock's prospects.
Enterprise Value Revenue 12.354 | Revenue 520.2 M | Quarterly Revenue Growth 0.669 | Revenue Per Share 2.851 | Return On Equity (0.28) |
Legend Biotech Corporate Filings
| 14th of November 2024 Other Reports | ViewVerify | |
6K | 12th of November 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
13A | 5th of April 2024 An amended filing to the original Schedule 13G | ViewVerify |
Legend Biotech Earnings per Share Projection vs Actual
Legend Biotech Corporate Management
| Elaine Qian | VP Resources | Profile | |
| James JD | General Counsel | Profile | |
| Lori CPA | Chief Officer | Profile | |
| Guowei Fang | Chief Development | Profile | |
| Tina Carter | Corporate Lead | Profile | |
| Steven Gavel | US Development | Profile | |
| Marc Harrison | VP Counsel | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Legend Biotech Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend Biotech. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.92) | Revenue Per Share 2.851 | Quarterly Revenue Growth 0.669 | Return On Assets (0.12) | Return On Equity (0.28) |
The market value of Legend Biotech Corp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend Biotech's value that differs from its market value or its book value, called intrinsic value, which is Legend Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend Biotech's market value can be influenced by many factors that don't directly affect Legend Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.